Therapy News and Research

RSS

That mistake will cost you and your brain knows staight away!

According to a team of researchers in the U.S.a particular part of the brain called the rostral anterior cingulate cortex, or rACC, becomes much more active when a person realizes he or she has made an error that carries consequences - for instance, losing money.

12 Apr 2006

Review examines the management of radiotherapy induced rectourethal fistula

Rectourethral fistulas (RUF) are a challenging problem observed by urological and colorectal surgeons.

11 Apr 2006

Usage and outcomes of primary androgen deprivation therapy for localized prostate cancer

In the online March 2006 version of Cancer, Dr. Kawakami and associates report from the CaPSURE database that primary androgen deprivation therapy (PADT) is used in 14% of prostate cancer (CaP) patients with reasonable outcomes at approximately 5 years follow-up.

11 Apr 2006

Interstitial cystitis average cost in first year after diagnosis $3000 or more

Wu and colleagues studied data for patients under age 65 with at least one diagnosis of Interstitial Cystitis (IC) from a de-identified administrative database of 2 million beneficiaries that included medical, drug and disability claims for 1999-2002.

11 Apr 2006

Study assesses formularies across Medicare drug plans

Medicare's new private stand-alone drug plans vary significantly - in terms of covered drugs, out-of-pocket costs for specific medications, and restrictions placed on the use of certain drugs - according to a new analysis released today by the Kaiser Family Foundation.

11 Apr 2006

New insights into how anti-rejection drug daclizumab (Zenapax) helps MS patients

A research team led by the University of Cincinnati's Bibiana Bielekova, MD, report new insights into the role of the MS drug daclizumab (Zenapax) in the Proceedings of the National Academy of Sciences.

11 Apr 2006

Dealing with children's misbehavior

When children's misbehavior or delinquency creates problems, it's not enough to deal with the children alone. Mental health professionals recommend behavioral parent training as well, reports the April issue of Harvard Mental Health Letter.

11 Apr 2006

Oral post-surgical complications following the administration of bisphosphonates given for osteopenia related to malignancy

The patient of a periodontist in private practice in New Orleans developed osteonecrosis of the jaw (ONJ), a condition that can cause severe, often irreversible and debilitating damage to the jaw, following periodontal surgical therapy.

11 Apr 2006

Dasatinib provides significant benefit in chronic myeloid leukemia patients resistant to Gleevec

A study led by researchers from the Howard Hughes Medical Institute has found that dasatinib provides significant benefit in chronic myeloid leukemia (CML) patients resistant to Gleevec. (imatinib), according to a study presented during the 97th Annual Meeting of the American Association for Cancer Research.

11 Apr 2006

Estrogen-alone hormone therapy does not increase the risk of breast cancer in postmenopausal women

The results contrast with the previously reported WHI Estrogen plus Progestin Trial, which found an increase in breast cancer over about 5 years among those taking combined hormone therapy.

11 Apr 2006

Mount Sinai launches CombiRx trial to treat relapsing-remitting Multiple Sclerosis

Mount Sinai School of Medicine is the Clinical Coordinating Center for the first study to assess the effectiveness of combining two FDA approved medications as initial treatment for people with Relapsing Remitting Multiple Sclerosis.

11 Apr 2006

Stem cells can repair damaged spinal tissue and help restore function in rats with spinal cord injuries

Each year, some 11,000 Americans sustain spinal cord injury, most often in traffic accidents. Costs of the condition approach $10 billion per year.

11 Apr 2006

Estrogen therapy increases the risk of blood clots in some women

According to new research postmenopausal women on estrogen therapy who have undergone a hysterectomy have an elevated risk of developing a blood clots in veins.

11 Apr 2006

Forget the diet, just zap that fat!

Scientists in the U.S. are in the process of developing a laser which melts fat and they believe that in future it could be used to treat heart disease, cellulite, and acne.

11 Apr 2006

Single dose of stem cells produce robust behavioral recovery in animal models for stroke, cerebral palsy

A single dose of adult donor stem cells given to animals that have neurological damage similar to that experienced by adults with a stroke or newborns with cerebral palsy can significantly enhance recovery from these types of injuries, researchers say.

11 Apr 2006

Research explains why recipients of growth hormone therapy may develop colon polyps

The use of growth hormone therapy has been linked in some people to the development of colon polyps, a possible precursor to colorectal cancer - but medical researchers have debated the extent of a cancer risk.

11 Apr 2006

Lubricin research points to future therapies for osteoarthritis

New evidence to explain how the body's natural joint lubricant prevents the wear and tear that can lead to osteoarthritis has been uncovered by researchers at Duke University's Pratt School of Engineering.The findings may lead to new methods for treating arthritis, the researchers said.

11 Apr 2006

Losartan can prevent progression of Marfan syndrome

A commonly prescribed blood pressure medication may provide the first ray of hope in preventing potentially deadly complications of Marfan syndrome, a genetic disease that weakens the structural meshwork of blood vessels.

11 Apr 2006

Guidelines for medication withdrawal

Although thousands of scientific papers evaluate and compare new and established drugs each year, providing evidence to help doctors prescribe safe and effective doses, almost no studies focus on when or how to stop these medications, even late in life.

11 Apr 2006

Lack of response to herceptin may be reversed with PI3K inhibiting agents

Breast cancer patients with HER2-positive tumors who don't respond to Herceptin (trastuzumab) may benefit from cocktail therapy that includes Herceptin along with one or more PI3K inhibiting agents, say researchers at the University of Texas M. D. Anderson Cancer Center.

11 Apr 2006

Therapy News and Research

That mistake will cost you and your brain knows staight away!

Review examines the management of radiotherapy induced rectourethal fistula

Usage and outcomes of primary androgen deprivation therapy for localized prostate cancer

Interstitial cystitis average cost in first year after diagnosis $3000 or more

Study assesses formularies across Medicare drug plans

New insights into how anti-rejection drug daclizumab (Zenapax) helps MS patients

Dealing with children's misbehavior

Oral post-surgical complications following the administration of bisphosphonates given for osteopenia related to malignancy

Dasatinib provides significant benefit in chronic myeloid leukemia patients resistant to Gleevec

Estrogen-alone hormone therapy does not increase the risk of breast cancer in postmenopausal women

Mount Sinai launches CombiRx trial to treat relapsing-remitting Multiple Sclerosis

Stem cells can repair damaged spinal tissue and help restore function in rats with spinal cord injuries

Estrogen therapy increases the risk of blood clots in some women

Forget the diet, just zap that fat!

Single dose of stem cells produce robust behavioral recovery in animal models for stroke, cerebral palsy

Research explains why recipients of growth hormone therapy may develop colon polyps

Lubricin research points to future therapies for osteoarthritis

Losartan can prevent progression of Marfan syndrome

Guidelines for medication withdrawal

Lack of response to herceptin may be reversed with PI3K inhibiting agents

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News